908 organization(s) found
Junshi Biosciences
Established in 2012, Junshi Biosciences is an innovation-driven biopharmaceutical company committed to developing first-in-class and best-in-class drugs through original innovation. With an outstanding capacity for innovative drug discovery, advanced biotechnology research and development, a whole-industry-chain approach with large-scale production technology, and drug combinations with great market potential, Junshi Biosciences has endless potential in onco-immunotherapy as well as the treatment of autoimmune diseases, metabolic diseases and infectious diseases.
Kahimmune Therapeutics
Kahimmune Therapeutics is an immuno-oncology company focused on discovering novel tumor-specific antigens to support the development of next-generation cancer vaccines and combination immunotherapies. Leveraging a proprietary immunopeptidomics and bioinformatics platform, Kahimmune explores non-canonical regions of the human genome that give rise to previously unrecognized tumor antigens.
Kanaph Therapeutics
From Human genome analysis to ADC: We are developing next-generation therapies through advanced technology
Karyopharm Therapeutics
Pharmaceutical company that develops nuclear export inhibitors for blood cancers.
KENCO (Kenya Network of Cancer Organisations)
Network representing community-based cancer organisations active in awareness, screening, prevention, and patient support across Kenya.
KESHO (Kenya Society of Haematology & Oncology)
The Kenya Society of Haematology and Oncology (KESHO) was founded in 2002 with the objective of carrying out research in cancer and blood diseases, improving patient care and providing physicians with fora to discuss ideas for purposes of improving practice and outcomes. KESHO is a professional society of haematologists and oncologists who through its members: Provides the necessary clinical care and treatment to all cancer patients in the country. Is heavily involved in the training of medical oncologists, oncology nurses, clinical oncologists, gynaecology oncologists, medical physicists and radiation technicians as well as enhancing medical knowledge of cancer to all cadres of health care workers such as clinical and medical officers as well as nurses. Is actively engaged in cancer research in the country and the region for improvement of outcomes for cancer patients. Is also a key stakeholder to national policies around cancer. Its members are involved in all five pillars of the National Cancer Control Program, committee for National Cancer Guidelines, National Screening guidelines as well as Standardized Curriculum on training health care workers on cancer among other committees. Its members were instrumental in the document behind the National Cancer Act. Engages with other civil society organisations such as the Kenya Network of Cancer Organisations, Kenya Cancer Association and many others in advocating for better cancer services and providing professional support for these organizations. Has been involved in cancer screening and treatment for thousands of Kenyans. Is associated with the African Organization of Research and Treatment in Cancer (AORTIC), the Union for International Cancer Control and the American Society of Clinical Oncology (ASCO).
Kindling Bio
Kindling Bio is an award-winning company putting children affected by cancer first in a new wave of immunotherapy. We are pioneering a gene therapy platform built to overcome the unacceptable historic neglect and market fragmentation which continues to cause suffering for children and their families. By harnessing the strengths of the immune system to eliminate cancer, we are creating safer and more effective treatments for growing bodies, and beyond.
King Faisal Specialist Hospital & Research Centre
Saudi tertiary hospital with a large stem cell transplantation programme.
KiraGen Bio
Smarter Cell Therapies That Tune Out Tumor Suppression: Off-the-shelf cell therapies that ignore suppressive signals and keep fighting where others fade. First stop: GBM
Kite Pharma (a Gilead company)
Biotechnology company that develops and sells CAR-T cell therapies for blood cancers.